Ichor Medical Systems, Incorporated Contract Details

Defense contract under the Defense Threat Reduction Agency awarded to Ichor Medical Systems, Incorporated on 12/27/2012.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.

Contractor: Ichor Medical Systems, Incorporated
Department: Defense Threat Reduction Agency
Awarded: 12/27/2012

Ichor Medical Systems Inc., San Diego, Calif., (HDTRA1-13-C-0006) is being awarded a $3,559,589 cost-plus-fixed-fee research and development contract for the clinical assessment of a Multivalent Alphavirus DNA vaccine delivered by Electroporation. This contract includes options which, if exercised, would bring the cumulative value of this contract to $11,036,503. Work will be performed at San Diego, Calif., and is expected to be completed by Dec. 19, 2016. Solicitation was issued for full and open competition and 56 proposals were received. Contract funds in the amount of $3,356,162 will be obligated at the time of award and contract funds will not expire at the end of the current fiscal year. Defense Threat Reduction Agency, Fort Belvoir, Va., is the contracting activity.

Total Contract Value: $3,559,589

View all contracts that include "Ichor Medical Systems, Incorporated" in the MiC database.